0000000000890263

AUTHOR

Frédéric Roche

showing 2 related works from this author

Dynamic Force Production Capacities Between Coronary Artery Disease Patients vs. Healthy Participants on a Cycle Ergometer

2020

Background: The force-velocity-power (FVP) profile is used to describe dynamic force production capacities, which is of great interest in training high performance athletes. However, FVP may serve a new additional tool for cardiac rehabilitation (CR) of coronary artery disease (CAD) patients. The aim of this study was to compare the FVP profile between two populations: CAD patients vs. healthy participants (HP). Methods: Twenty-four CAD patients (55.8 ± 7.1 y) and 24 HP (52.4 ± 14.8 y) performed two sprints of 8 s on a Monark cycle ergometer with a resistance corresponding to 0.4 N/kg × body mass for men and 0.3 N/kg × body mass for women. The theoretical maximal force (F 0) and velocity (V…

medicine.medical_specialtyAcute coronary syndromecycle sprintPhysiologyPhysical activityphysical activitykuntotestitforce-velocity-power relationship030204 cardiovascular system & hematologylcsh:Physiologyacute coronary syndromeCoronary artery disease03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicinemedicineCycle ergometervoimantuotto (fysiologia)Exercise physiologykuntoutujatOriginal Researchexercise physiologySedentary timelcsh:QP1-981business.industrySignificant differenceliikuntafysiologiahealth030229 sport sciencesmedicine.diseasecardiac rehabilitationsydän- ja verisuonitauditCardiologykuntoutusbusinessFrontiers in Physiology
researchProduct

Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged ≥60 years: a systematic review and meta-analysis

2015

Type de document : revue de littérature; International audience; Background The health benefits of 150 min a week of moderate-to-vigorous-intensity physical activity (MVPA) in older adults, as currently recommended, are well established, but the suggested dose in older adults is often not reached.Objectives We aimed to determine whether a lower dose of MVPA was effective in reducing mortality, in participants older than 60 years.Methods The PubMed and Embase databases were searched from inception to February 2015. Only prospective cohorts were included. Risk ratios of death were established into four doses based on weekly Metabolic Equivalent of Task (MET)-minutes, defined as inactive (refe…

GerontologyMalemedicine.medical_specialtyPediatricslife-styleHealth Behaviorcardiovascular-diseasePhysical Therapy Sports Therapy and Rehabilitation030204 cardiovascular system & hematologyMetabolic equivalent03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemRisk FactorsExercise/physiologymedicinefollow-upHumansOrthopedics and Sports Medicine030212 general & internal medicineolder-adultsExercise physiologyMortalityExerciseddc:613Agedriskbusiness.industryPublic healthfood and beveragesGeneral MedicineMiddle Agedleisure-timeRandom effects modelbase-lineheart-disease3. Good healthInstitutional repositoryMeta-analysisRelative riskall-cause mortalityFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiewomenbusinesshuman activitiesCohort study
researchProduct